Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Magnetic Resonance Imaging × Genitourinary × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Breast 2 Thoracic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 60 Specimen Handling 51 pembrolizumab 35 Nivolumab 33 Gemcitabine 30 enzalutamide 27 Docetaxel 27 apalutamide 25 Prednisone 24 Abiraterone Acetate 24 Biopsy 22 cabozantinib 20 Radiosurgery 20 Cisplatin 20 Pluvicto 18 Carboplatin 17 Ipilimumab 16 darolutamide 15 Androgen Antagonists 14 enfortumab vedotin 12 olaparib 11 Radiotherapy 11 erdafitinib 10 atezolizumab 10 abiraterone 10 Standard of Care 10 Radiation 10 Platinum 10 Leuprolide 10 durvalumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06280781 2026-03-30

IP9-ATLAS

Imperial College London

Phase NA Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡